Skip to content
10-Q

Quarterly Report

DNA Testing Centers Corp

0001493152-19-010385

← back to feed
Filed
Jul 9, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Jun 4, 2019 21.5M sh
Operating Cash Flow Q2 2017 · Jun 30, 2017 −$6.17K
Operating Cash Flow restated Q2 2017 · Jun 30, 2016 −$42.32K
Cash And Equivalents Q2 2017 · Jun 30, 2017 $7.51K
Cash And Equivalents Q2 2017 · Dec 31, 2016 $3.78K
Cash And Equivalents Q2 2017 · Jun 30, 2016 $2.9K
Cash And Equivalents Q2 2017 · Dec 31, 2015 $207
Stockholders Equity Q2 2017 · Jun 30, 2017 −$114.98K
Stockholders Equity Q2 2017 · Dec 31, 2016 −$109.53K
Total Liabilities Q2 2017 · Jun 30, 2017 $128.44K
Total Liabilities Q2 2017 · Dec 31, 2016 $119.54K
Current Assets Q2 2017 · Jun 30, 2017 $9.75K
Current Assets Q2 2017 · Dec 31, 2016 $6.19K
Total Assets Q2 2017 · Jun 30, 2017 $13.46K
Total Assets Q2 2017 · Dec 31, 2016 $10.01K
Net Income Q2 2017 · Jun 30, 2017 −$1.91K
Net Income Q2 2017 · Jun 30, 2017 −$2.96K
Net Income Q2 2017 · Jun 30, 2016 −$77.12K
Net Income Q2 2017 · Jun 30, 2016 −$94.58K
Gross Profit Q2 2017 · Jun 30, 2017 $11.96K
Gross Profit Q2 2017 · Jun 30, 2017 $25.83K
Gross Profit Q2 2017 · Jun 30, 2016 $2.28K
Gross Profit Q2 2017 · Jun 30, 2016 $3.06K